Related references
Note: Only part of the references are listed.Sub-optimal cholesterol response to initiation of statins and future risk of cardiovascular disease
Ralph Kwame Akyea et al.
HEART (2019)
Sphingolipids and their metabolism in physiology and disease
Yusuf A. Hannun et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Multidrug-resistant Pseudomonas aeruginosa aggravates inflammatory responses in murine chronic colitis
Eliane von Klitzing et al.
SCIENTIFIC REPORTS (2018)
Gut microbiota and intestinal FXR mediate the clinical benefits of metformin
Lulu Sun et al.
NATURE MEDICINE (2018)
Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
Hao Wu et al.
NATURE MEDICINE (2017)
The mechanisms of action of metformin
Graham Rena et al.
DIABETOLOGIA (2017)
Statins increase hepatic cholesterol synthesis and stimulate fecal cholesterol elimination in mice
Marleen Schonewille et al.
JOURNAL OF LIPID RESEARCH (2016)
Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease
S. Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
Kristoffer Forslund et al.
NATURE (2015)
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Christopher P. Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The pharmacology of statins
Cesare R. Sirtori
PHARMACOLOGICAL RESEARCH (2014)
Signal transducer and activator of transcription 3-mediated regulation of miR-199a-5p links cardiomyocyte and endothelial cell function in the heart: a key role for ubiquitin-conjugating enzymes
Arash Haghikia et al.
EUROPEAN HEART JOURNAL (2011)
Enteric Microbiome Metabolites Correlate with Response to Simvastatin Treatment
Rima Kaddurah-Daouk et al.
PLOS ONE (2011)
Increased Levels of Plasma Acylcarnitines in Obesity and Type 2 Diabetes and Identification of a Marker of Glucolipotoxicity
Stephanie J. Mihalik et al.
OBESITY (2010)
Bacteroides sp strain D8, the first cholesterol-reducing bacterium isolated from human feces
Philippe Gerard et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2007)
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice
Fredrik Backhed et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Gram-negative bacteria aggravate murine small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii
Markus M. Heimesaat et al.
JOURNAL OF IMMUNOLOGY (2006)
Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption
SW Altmann et al.
SCIENCE (2004)
Share Paper
